IMARC Group, a leading market research company, has recently releases report titled " Transdermal Skin Patches Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028. " The study provides a detailed analysis of the industry, including the global transdermal skin patches market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report HighlightsHow big is the Transdermal Skin Patches Market?The global transdermal skin patches market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.4% during 2023-2028.
What is Transdermal Skin Patches?A transdermal skin patch is a medicated adhesive patch that contains medication and is attached to the skin. The body absorbs the medication from the patch over a period of time through the diffusion technique, which eventually gets released into the bloodstream. They contain drugs, backings, adhesives, liners, membranes, permeators, low electrical currents like iontophoresis, and physical aids. It is used for treating Parkinson's disease, osteoporosis, cardiac and hormonal disorders, Alzheimer's, migraine, strokes, dermatology-related issues, HIV, and restless leg syndrome treatments. In recent years, transdermal skin patches are gaining momentum due to their widespread utilization as topical, cosmetic, and transdermal delivery systems.
Request for a free sample copy of this report: https://www.imarcgroup.com/transdermal-skin-patches-market/requestsampleWhat are the growth prospects and trends in the Transdermal Skin Patches Industry?One of the primary factors driving the market is the increasing number of individuals diagnosed with chronic ailments. Additionally, the ease of administration is boosting the market demand as it improves the compliance of the patient during smoking cessation therapy and treatment of chronic pains.
Other than this, transdermal skin patches offer advantages over oral and ingesting medications, such as it prevents gastrointestinal toxicity, vomiting, and nausea, and lowers the inconvenience caused due to intravenous or parenteral therapies, thus positively influencing the market growth. Besides this, the increasing number of clinical trials and the rising demand for better therapeutics at economical rates are creating a positive market outlook.
Furthermore, key players are extensively investing in research and development (R&D) activities to introduce new product variants, such as pressure-sensitive adhesives and permeation enhancers, to provide a better consumer experience, increase their customer base, and enhance their product portfolio.
What is included in market segmentation?The report has segmented the market into the following categories:
Breakup by Type:- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Stores
- Pain Relief
- Smoking Reduction and Cessation Aid
- Overactive Bladder
- Hormonal Therapy
- Others
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
The report covers the major market players including:
3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group?, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5142&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.About UsIMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact USIMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
